Thursday, May 11, 2017

Delayed Note of How the Week Started - France Dodged a Bullet

Hey!  Sorry for being scarce on the blog front.  I was in the process of relocating for the time being to help out a seriously ill relative and have been busy doing all the usual moving related stuff.  While I still have a lot to do I thought it prudent to come on here briefly for a couple of post. 

We all know the big topic filling the room and we'll get to that in the next post.  But, for now, let's take a step back and remind ourselves how the week started. 

Yes, it's hard to believe only a few days ago the big news was the French election last Sunday where far right candidate for the National Front Marine Le Pen was steadily trounced by centrist Emmanuel Macron for the Presidency of the country.  While the centrism of Macron is far from great in a lot of ways, the fact that he beat the candidate some were comparing to electoral vote winner Trump by over 30 points is a massive sigh of relief in a world still dealing with Britain's Brexit vote and the current state of the U.S.

To be fair, a case can be made that this election had the lowest voter turnout in France since 1969.  However, their low voter turnout rate was 74%, a percentage that would probably scare the crap out of both the Repubs and establishment Democrats.  Thus, it's safe to say that the victory of Macron was legit. 

That doesn't mean it's over, Macron's party is still struggling to process candidates for elections to Parliament.  In addition there are three more European countries with elections coming up that could foretell the direction of the European Union, if not the continent's political leanings altogether.  Still, the fact that centrism beat a party that in the past had some openly neofacist tendencies (and may still have them under the surface) got the week off to a start that many thought would relieve some of the hype about the Repubs victory optics over the House repeal of the ACA. 

Little did anyone know what turns the next couple of days would take.

No comments: